Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
36
NCT03316131
A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA
Phase: Phase 2
Role: Collaborator
Start: Oct 25, 2017
Completion: Jul 19, 2018